noscript

News and Announcements

OncoSil Pancreatic Cancer Clinical Study Update

  • Published November 28, 2016 11:44AM UTC
  • Publisher Wholesale Investor
  • Categories Company Updates

28th November 2016, ASX Announcement

OncoSil Medical Limited (ASX: OSL) (OncoSil Medical or the Company) a medical device company focused on localised treatments for patients with pancreatic and liver cancer, is pleased to provide an update on its global OncoPaC clinical study programme.

Highlights

  • Johns Hopkins Hospital and MD Anderson Cancer Centre are the leading U.S. centres.
  • Investigational Review Board (IRB) process has commenced and is on-going for these two U.S. centres. • Guy’s and St Thomas’ Hospitals, London are the leading UK centres.
  • Monash Health has agreed to be the lead Australian centre – ethics submission filed and under review.

To view the full announcement, please click on the button below.

Capital Insights
The Index Approach in Early-Stage Venture Capital: Reconsidered

The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]

Capital Insights
The Future Is Now: The Evolution of Dealflow with Wholesale Investor

If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]

Join over 45,000+ sophisticated investors

Join Now